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The basic helix– loop–helix (bHLH) transcription factor, neuroD2, induces neuronal differentiation and promotes neuronal survival.
Reduced levels of neuroD2 were previously shown to cause motor deficits, ataxia, and seizure propensity. Because neuroD2 levels may be
critical for brain function, we studied the regulation of neuroD2 gene in cell culture and transgenic mouse models. In transgenic mice, a 10-kb
fragment of the neuroD2 promoter fully recapitulated the endogenous neuroD2 staining pattern. A 1-kb fragment of the neuroD2 promoter
drove reporter gene expression in most, but not all neuroD2-positive neuronal populations. Mutation of two critical E-boxes, E4 and E5 (E4
and E5 situated 149 and 305 bp upstream of the transcriptional start site) eliminated gene expression. NeuroD2 expression was diminished in
mice lacking neurogenin1 demonstrating that neurogenin1 regulates neuroD2 during murine brain development. These studies demonstrate
that neuroD2 expression is highly dependent on bHLH-responsive E-boxes in the proximal promoter region, that additional distal regulatory
elements are important for neuroD2 expression in a subset of cortical neurons, and that neurogenin1 regulates neuroD2 expression during
mouse brain development.
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NeuroD2/NDRF/KW8 (hereafter neuroD2) plays a crit-
ical role in neuronal differentiation and survival. Like the
related neurogenic basic helix–loop–helix (bHLH) tran-
scription factor neuroD1/beta2, neuroD2 is sufficient to
convert non-neuronal cells into neurons in a Xenopus
model. NeuroD2 also induces neuronal differentiation in
mammalian P19 embryonal carcinoma cells, to a greater
degree than other neurogenic bHLH transcription factors
tested (Farah et al., 2000). Mice deficient for neuroD2
experience excessive apoptosis in central nervous system0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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1 CHL and JS contributed equally to this work.populations that normally express neuroD2. These mice
exhibit small brains, ataxia, reduced seizure threshold,
growth failure, and early death (Olson et al., 2001). Mice
that were heterozygous for neuroD2 exhibited the same
deficits as neuroD2-null mice, though not as severe. This
haploinsufficiency phenotype in mice raised the possibility
that neuroD2 expression levels may influence human brain
development and function. Since neuroD2 participates in
genesis of neurons involved in learning, memory, coordi-
nation, and cranial nerve function, it is important to under-
stand how the gene is regulated in the central nervous
system.
In the developing mouse brain, neuronal determination
proteins such as neurogenin1, neurogenin2, and MASH1
commit multipotent progenitors to a neuronal rather than
astroglial fate (Nieto et al., 2001; Sun et al., 2001). In
Xenopus, chick, and zebrafish, neurogenins induce expre-
ssion of neuroD (Blader et al., 1997; Koyano-Nakagawa
et al., 1999; Perez et al., 1999). Regulation of neuroD family
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the absence of neuroD1 expression in precursors of cranial
sensory nerves of neurogenin-null mice (Fode et al., 1998;
Ma et al., 1998). In telencephalon, neurogenin expression
begins at E8.5, peaks at E11–14, and wanes by E16 in
mouse brain (Ma et al., 1998). Neurogenin2 peaks in a
similar fashion and is maintained into late embryonic and
early postnatal stages. Concurrent with peak expression of
neurogenin1 and neurogenin2, neuroD1 and neuroD2
mRNAs become detectable (E10.5 and E11, respectively).
Neurogenins bind to E-box promoter elements (CANNTG)
and have been shown to induce transcription driven by
neuroD1 and neuroD2 promoter fragments in cell lines
(Farah et al., 2000; Huang et al., 2000; Oda et al., 2000).
In neuroendocrine cells, neurogenin3 positively regulates
the expression of neuroD1 promoter-driven reporter con-
structs through two E-box sequences (CAGATG and CAT-
ATG) that are located within 400 bp upstream of the
transcriptional start site. Similarly, neurogenin1 activation
of a neuroD2 promoter-reporter construct is reduced by
mutation of a CAGATG E-box (E4, located 149 bp up-
stream of exon 1) in P19 embryonal carcinoma cells (Oda et
al., 2000).
In this study, we confirm that E4 is necessary for
neurogenin1 regulation of neuroD2. We also show that a
nearby E-box, E5, is necessary for full neurogenin1 activity.
Toward the goal of understanding neuroD regulation in
mammalian brain, we report for the first time a detailed
analysis of the brain regions in which the endogenous
neuroD2 promoter is active. This expression pattern is fully
recapitulated in mice that transgenically express the lacZ
gene driven by a 10-kb fragment of the neuroD2 promoter
(10 kb:lacZ mice) and largely recapitulated by a 1-kb
fragment (1 kb:lacZ mice). Mutation of E4 and E5 in the
1 kb:lacZ mice completely abrogates transcriptional activity
in mouse brain demonstrating that the neurogenin- and
neuroD-responsive elements are critical for induction and
maintenance of neuroD2 expression. Finally, we show that
the neuroD2 promoter is inactive in certain populations of
developing neurons that lack neurogenin, providing direct
evidence that this neuronal determination factor is necessary
for activation of the neuroD2 promoter in certain mamma-
lian neuronal populations.Materials and methods
Plasmid construction
A 10-kb fragment of DNA immediately upstream of the
neuroD2 transcription start site was isolated during the
initial cloning of neuroD2 (McCormick et al., 1996). The
pPD46.21 plasmid was used as the backbone for h-galac-
tosidase reporter constructs and the pGL3 basic plasmid was
used as the backbone for luciferase reporter constructs. The
1-kb fragment and deletion mutants of the 1-kb fragmentwere generated using standard cloning techniques. Point
mutations were generated using the QuikChange Site-Di-
rected Mutagenesis Kit (Stratagene) with PCR primers
containing the specified mutation (original E4 sequence:
TAG AGA GTG ACA GAT GGC GGC GGG TCC CGG;
mutant E4: TAG AGA GTG AAA GCT TGC GGC GGG
TCC CGG; original E5 sequence: CCA TTG TTC CCA
TGT GGG GGG TTC TAT ATC; mutant E5: CCA TTG
TTC CCT GCA GGG GGG TTC TATATC). All constructs
were sequenced to verify the absence of unintended muta-
tions and the presence of intended mutations. In particular,
the E4/E5 mutant constructs were shown to have an intact
transcription start site and no mutations other than the
intended E-box mutations.
In vitro transfection
P19 embryonal carcinoma cells were maintained in
subconfluent monolayers in DMEM with 10% fetal bovine
serum and 5% bovine calf serum (FBS and BCS; Hyclone,
Logan, UT). NSH neuroblastoma cells were maintained in
DME with 10% BCS. Cells in 35-mm dishes were trans-
fected with 2.1 Ag of DNA (total) using FuGENE 6
transfection reagent according to manufacturer’s directions
(P19 cells) or 4.1 Ag of DNA using Superfect reagent (NSH
cells) (FuGENE: Roche; Superfect: Qiagen). h-galactosi-
dase and luciferase assays were conducted 48 h after trans-
fection unless otherwise noted using previously described
techniques (Olson et al., 2001).
EMSA methods
NeuroD1, neuroD2, neurogenin1, neurogenin2, E12 pro-
teins (and empty CS2) vector were prepared using TNT
coupled wheat germ in vitro transcription/translation ex-tract
system (Promega). For gel mobility shift assays, 5 ml samples
of each protein were first incubated together at 37jC for 20
min. Each protein mix was subsequently incubated with
approximately 50,000 cpm of 32P-labeled double-stranded
oligonucleotide probe at room temperature for 15 min in the
binding buffer: 20 mM Hepes (pH 7.6), 50 mM KCl, 1 mM
EDTA, 1 mM dithiothreitol, 5% glycerol, and 1 Ag double-
strand poly dI-dC. The DNA–protein complex was resolved
on 5% polyacrylamide gel at room temperature. The follow-
ing probes were used: E4 (AGAGTGACAGATG-
GCGGCGG), E5 (TTGTTCCCATGTGGGGGGTT),
mutE4 (AGAGTGAAAGCTTGCGGCGG), and mutE5
(TTGTTCCCTGCAGGGGGGTT).
Generation and analysis of transgenic mice
Transgenic mice were generated through the University
of Washington Department of Comparative Medicine Trans-
genic Core and maintained in the Fred Hutchinson Cancer
Research Center Animal Health Resource facility in accor-
dance with federal and institutional regulations. Fragments
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the h-galactosidase gene, and a polyA sequence were
isolated by restriction digest (1 kb digested with EagI, 10
kb digested with PstI–EagI), purified using Schleicher and
Schuell columns according to the manufacturer’s directions,
and provided to the transgenic core for zygote (E0.5
fertilized eggs) injection. Transgene presence was confirmed
on genomic DNA derived from tail or toe using PCR with
the following primers AATCTCTGCTTTTCCTGCG-
TTGGG (forward) and GGGCGATCGGTGCGGG-
CCTCTTCGC (reverse). Southern analysis was performed
using genomic DNA cut with BamHI and NdeI for 10
kb:lacZ mice and with EcoRI for 1 kb:lacZ and mutE4E5:
lacZ mice, using the 1 kb promoter fragment as probe. We
analyzed at least two independent lines from the 10 kb:lacZ
and 1 kb:lacZ transgenic mice totaling the following numb-
ers: 10 kb:lacZ mice: 6 embryos and 8 adults; 1 kb:lacZ
mice: 7 embryos and 32 adults. We also analyzed four
independent lines of mutE4E5:lacZ transgenic mice tota-
ling six embryos and eight adults. There were no consist-
ent differences between lines generated from the same
construct.
X-gal staining of embryos
Timed-pregnant females were anesthetized with avertin
and euthanized by cervical dislocation. Embryos were
removed, rinsed briefly in ice-cold PBS, and then incubat-
ed for 2 h at 4jC in fixative solution (2% formaldehyde
and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH
7.3) with gentle agitation. The fixed embryos were washed
three times with rinse solution (0.01% sodium deoxycho-
late, 0.02% NP-40, 2 mM MgCl2 in 0.1 M phosphate
buffer, pH 7.3) and then soaked in X-gal solution contain-
ing 2 mM MgCl2, 20 mM K3Fe(CN)6, 20 mM K4Fe(CN)6,
0.01% sodium deoxycholate, 0.02% NP-40, and 10 mg/ml
X-gal in 0.1 M phosphate buffer. Stained embryos were
rinsed with PBS, paraffin embedded, and then cut into 12-
Am sections. Following deparaffinization, sections were
counterstained with Fast Red (Vector Laboratories, Burlin-
game, CA).
X-gal staining and anti-b-galactosidase antibody
immunostaining for postnatal mice
Postnatal and adult mice were anesthetized with avertin
and perfused with PBS and then 4% paraformaldehyde.
Both 50- and 500-Am sections were cut by vibratome in cold
phosphate buffer and stained with X-gal solution as de-
scribed previously. Subsequently, after X-gal staining, the
500-Am sections were paraffin embedded, cut into 12-Am
sections, and then counterstained with Fast Red. For anti-h-
galactosidase antibody immunostaining, 50-Am sections
were cut by vibratome in cold phosphate buffer, blocked
with 10% normal goat serum, 2% BSA, 0.1% Triton X-100
in PBS, incubated with 1:500 dilution of monoclonal anti-h-galactosidase antibody (Promega), and then incubated with
rhodamine- or FITC-conjugated secondary antibody.
Analysis of double mutants of neurogenin1:neuroD2 and
neurogenin2:neuroD2
Heterozygous neurogenin1 (ngn1) and neuroD2 (nd2)
males and females were bred to get ngn1/:nd2+/ and
ngn1+/:nd2+/. Two time points at E13.5 and P0.5 were
processed and analyzed by X-gal staining as described
previously. The same breeding strategy and analysis was
performed on ngn2:nd2 double mutants. Analyses were
performed on six ngn1:nd2 mice, six ngn2:nd2 mice and
six of each control.Results
Identification of necessary proximal promoter elements
Approximately 10- and 1-kb fragments immediately
upstream of the neuroD2 transcription start site were cloned
into reporter constructs. Preliminary experiments indicated
that the 10- and 1-kb fragments were both responsive to
endogenous transcription factors in subsets of P19 embry-
onal carcinoma and NSH neuroblastoma cell lines (not
shown). We first focused on the 1-kb fragment (Fig. 1A).
This fragment contains nine E-boxes (labeled E2–E10 from
proximal to distal according to the convention of Oda et al.,
2000).
A series of deletion and point mutants were generated
from this fragment and cloned into luciferase reporter
plasmids. In NSH neuroblastoma cells, neurogenin1 in-
creased the expression of the nonmutated 1 kb:luc reporter
79.7 F 9.1-fold. Neurogenin1 activity was retained in the
absence of E6 or E10 and most neurogenin activity was
retained in the absence of E7 and E8. Neurogenin1 failed
to induce all constructs that lacked E4 and E5 (Fig. 1B).
NeuroD2 increased the expression of the nonmutated 1
kb:luc reporter by 9.4 F 0.6-fold. Like neurogenin1,
neuroD2 had minimal activity on constructs that lacked
E4 and E5, but showed baseline activity on other mutants
(Fig. 1B).
To further explore the role of E4 and E5, these sites
were altered by site-directed mutagenesis, cloned into
luciferase reporter constructs, and co-transfected with neu-
rogenin, neuroD2, or vector control DNA into NSH neu-
roblastoma cells (Fig. 1C). Compared to control, neuro-
genin1 increased activity of the parent vector (D 1003
to 506, refer to Fig. 1B), 62 F 46.2-fold but did not
activate the vector with mutated E4 (1.1 F 0.3-fold). The
activity on the construct with mutated E5 was diminished
to a lesser extent (11.3 F 5.6-fold). Induction of the
nonmutated vector was less for neuroD (10.6 F 4.8) and
neuroD2 (17.7 F 11.6) than neurogenin. The activity of
neuroD and neuroD2 were diminished by mutation of E4
                          
Fig. 1. Mutation analysis of the 1 kb:luciferase (luc) reporter construct in NSH cells. (A) Schematic of 10- and 1-kb constructs. Potential bHLH response
elements, E-boxes, are numbered E2–E10 using the convention of Oda et al. The sequence of each E-box is shown. (B) Transactivation of promoterless vector,
nonmutated 1 kb:luc reporter, or various mutated forms of the 1 kb:luc reporter by neurogenin1 (ngn) or neuroD2 in NSH neuroblastoma cells. The D symbol
and empty space represent the extent of deletions and the X represents mutations of individual E-boxes. Fold activation is reported as fold increase over empty
expression vector (CS2+) controls (n = 3–5). (C) Transactivation of D 1003 to 506:luc vector (parent) or the same construct with mutations in either E4
(mutE4) or E5 (mutE5) by ngn, neuroD, or neuroD2 (n = 3–6). Transactivation of a reporter construct consisting of multimerized E4 driving luc by the same
expression vectors (n = 2 for neuroD, n = 3 for others). For panels B and C, *P V 0.05 and **P < 0.005 for constructs compared to ND2-1.0 luc (panel B) or
D1003 to 506 (panel C). Absence of asterisks indicates that the reporter was not significantly different than the parent vector. EB4 P values are not shown
for EB4 luc because it was not a derivative of the parent vector.
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affected by mutation of E5 (11.4 F 9.4 and 9.3 F 8.0,
respectively). A reporter construct that utilized multimer-
ized E4 driving luciferase was activated 338 F 70.7-fold
by neurogenin, 38.2-fold by neuroD and 15.8 F 2.9-fold
by neuroD2 (Fig. 1C). This construct was not activated by
MASH1 (data not shown).To determine whether neurogenin and neuroD family
members directly bound to the sequences in E4 and E5,
we conducted electrophoretic mobility shift assays
(EMSA). NeuroD1, neuroD2, neurogenin1, and neuro-
genin2 bound to E4 (Fig. 2). None of these transcription
factors bound to E5. None of the neurogenin or neuroD
family members bound to the mutant forms of E4 and
Fig. 2. Electrophoretic mobility shift assay of neuroD1, neuroD2, neurogenin1 (ngn1), and neurogenin2 (ngn2) complexed with E12, using wild type and mutant E4 and E5 promoter elements. Panel A
demonstrates the binding of neuroD1, neuroD2, ngn1, and ngn2 to E4 and mutant E4 (mutE4) elements. Lanes 1–6 and 15–20 are controls for nonspecific (CS2) and monomeric (E12, neuroD1, neuroD2, ngn1,
ngn2) binding to wild type and mutE4 probes. Lanes 7, 9, and 11 show neuroD1, neuroD2, and ngn1 complexed with E12 binding to the E4 promoter element. Lane 13 shows ngn2/E12 weakly binding the E4
element. Lanes 8, 10, 12, and 14 show neuroD1, neuroD2, ngn1, ngn2 not binding the mutE4 probe. Panel B demonstrates the binding of neuroD1, neuroD2, ngn1, and ngn2 to E5 and mutant E5 (mutE5)
promoter elements. Lanes 1–6 and 15–18 are controls for nonspecific (CS2) and monomeric (E12, neuroD1, neuroD2, ngn1, ngn2) binding to wild type and mutE5 probes. Lanes 7–14 show neuroD1, neuroD2,
ngn1, and ngn2 complexed with E12 binding neither the E5 nor the mutE5 promoter elements. Lanes 19 and 20 provide positive controls of varying intensity (ngn2/E12 + E4, neuroD1/E12 + E4). WG, wheat
germ.
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Fig. 3. Expression pattern of a reporter driven by the endogenous neuroD2 promoter. Coronal sections (100 Am) from a neuroD2+/ mouse brain stained for h-
galactosidase activity. Sections shown are unevenly spaced from anterior to posterior, selected to demonstrate the following structures that express neuroD2
(panels referred to in parentheses): ACo, anterior cortical amygdaloid nuclei (C); AHiPM, amygdalohippocampal posteromedial nucleus (F); Apir,
amygdalopiriform transition area (F); BL, basolateral amygdala nuclei (D); BM, basomedial amygdala nucleus (E); Cn, cochlear nuclei (I); Coll, colliculus (H);
ctx, cerebral cortex (A); DCN, deep cerebellar nuclei (J); DG, dentate gyrus (B); Dk, nucleus of Darkschewitsch (F); Ecu, external cuneate nuclei (L); Gn,
geniculate nucleus (F); GL, cerebellar granule cell layer (I); Hb, habenular nuclei (D); La, lateral amygdaloid nucleus (D); ML, cerebellar molecular layer (I);
PAG, periaqueductal gray (F); PMCo, posteromedial cortical amygdala nuclei (F); Pe, paraventricular hypothalamic nuclei (E); Pn, pontine nuclei (H); Pr,
prepositus hypoglossal nucleus (K); Py, pyramidal nucleus (I); Sp5, spinal trigeminal nucleus (I); Su, supraocular nuclei (G); SuG, superficial grey layer (F);
SuM, supramammillary nuclei (F); Ve, vestibular nuclei (J). The olfactory bulb is not shown. Fiber tracts are not labeled.
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cribed above or the transgenic mouse studies described
below.
From in vitro studies, we conclude that 1- and 0.5-kb
fragments of the neuroD2 promoter are induced by neuro-
genin1 and neuroD2, that this activity is abolished by
mutation of both E4 and E5 bHLH response elements,
and that E4 is responsive to both neurogenin1 and neuroD
family members. In addition, E5 appears necessary for the
activation by neurogenin1, although the gel shift assay didnot show binding, perhaps indicating that other factors are
necessary for neurogenin1 to bind to E5.
Endogenous neuroD2 expression pattern
To gain insight into in vivo regulation of the neuroD2
gene, we utilized mice that express the lacZ gene in place
of the neuroD2 coding sequence to evaluate the popula-
tions of neurons in which the neuroD2 promoter is active
(Olson et al., 2001). In neuroD2+/ mice, lacZ staining
Fig. 4. Expression pattern of reporter driven by 10 and 1 kb neuroD2 promoter fragments and neuroD2+/. (A–C) Horizontal sections of 21-day-old
neuroD2+/, 10 kb:lacZ, and 1 kb:lacZ mice stained for h-galactosidase activity (left to right). Note that the 10 kb:lacZ and 1 kb:lacZ mice have a nuclear
localization signal (NLS) on the h-galactosidase gene, accounting for the difference in gross appearance between neuroD2+/mice, which lack the NLS. (D–F)
Hippocampus of adult neuroD2+/, 10 kb:lacZ, and 1 kb:lacZmice (left to right) shows consistent staining in dentate gyrus of all three lines. Arrow in F shows
absence of staining in CA3. Staining was weaker in CA1 and CA2 of 1 kb:lacZmice as well. (G– I) Cerebellum of neuroD2+/, 10 kb:lacZ, and 1 kb:lacZmice
(left to right) shows no consistent differences between lines. (J–L) Cerebral cortex of neuroD2+/, 10 kb:lacZ, and 1 kb:lacZ mice (left to right). Cortex layers
indicated by text on left of panel J; mz: marginal zone. The bracket in L shows absence of staining in most cortical layers of 1 kb:lacZmice. Panels D–L stained
with an antibody that recognizes h-galactosidase. (M–O) Embryos at E13.5 with neuroD2+/, 10 kb:lacZ, and 1 kb:lacZ genotype (left to right) stained for h-
galactosidase activity, then sectioned sagitally. i, Olfactory lobe; ii, neopallial cortex; iii, ventral midbrain; iv, intraventricular cerebellar primordium; v, dorsal
medulla oblongata. Again, the NLS in transgenic embryos causes more discrete staining than in neuroD2+/ embryos. Other abbreviations as in Fig. 3.
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Fig. 5. Effect of E4 and E5 mutation on neuroD2 promoter activity in mice. (A–F) Thick cut coronal sections (500 Am) through forebrain (top) and cerebellum
(bottom) of 10 kb:lacZ (A, D), 1 kb:lacZ (B, E), and mutE4E5:lacZ (C, F) mice stained for h-galactosidase activity. (G) Cross section of an E13.5
mutE4E5:lacZ embryo stained for h-galactosidase activity at the same time as embryos shown in Fig. 4. (H) Representative genomic Southern blot of two of
the four mutE4E5:lacZ transgenic lines with 1 kb:lacZ line as positive control.
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cortex (Fig. 3A and Table 1), CA1–3 and dentate gyrus of
the hippocampus (Figs. 3B and C), habenular thalamic
nuclei, paraventricular hypothalamic nuclei, lateral, baso-
lateral and basomedial amygdala nuclei (Figs. 3D and E),
periaqueductal gray, geniculate nuclei, supramammillary
nucleus, nucleus of Darkschewitsch, amygdalopiriform
transition area, posteromedial cortical amygdala nuclei,
amygdalohippocampal posteromedial nucleus (Fig. 3F),
supraocular nuclei (Fig. 3G), neurons in the colliculus,
pontine nuclei (Fig. 3H), and the pyramidal nucleus (Fig.
3I). Notably, the remaining regions of thalamus andhypothalamus were negative as were the entire basal
ganglia (Figs. 3A–D). In the cerebellum, granule cells,
molecular layer neurons, and deep cerebella nuclei were
positive and Purkinje cells were negative as previously
described (Figs. 3I–J). Brainstem neurons in the external
cuneate nucleus and central gray were positive and the
Raphe nucleus was negative (Fig. 3L). The neuroD2
promoter was active in many cranial nerve nuclei including
cochlear, spinal trigeminal (Fig. 3I), prepositus hypoglossal
(Fig. 3K), medial vestibular, and vestibular nuclei (Fig. 3J).
Sites of h-galactosidase expression are shown in Fig. 3 and
Table 1.
Fig. 6. Role of neurogenin1 and neurogenin2 in mouse brain neuroD2. E13.5 ngn1+/, neuroD2+/ embryos (A) show more h-galactosidase activity than ngn1/, neuroD2+/ embryos (B). The difference is
more pronounced at postnatal day P0.5 (C–D). E13.5 and P0.5 ngn2 wt, neuroD2+/ embryos (E, G, I) show similar h-galactosidase activity as ngn2/, neuroD2+/ embryos (F, H, J). Three mice were
evaluated for each condition, representative images are shown.
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Table 1
LacZ expression pattern in mouse models
Region NeuroD2+/ and 10 kb:lacZ 1 kb:lacZ Negative in all mice
Cerebral cortex layers All Faint layer 5, 6 subplate
Ventricular zone
NOT layers 2, 3
Hippocampus CA1, 2, 3
Dentate gyrus
Variable in CA1, 2, 3
Between mouse lines
Dentate gyrus
Thalamus Habenular nuclei Same Remainder of thalamus
Hypothalamus Paraventricular hypothalamic nuclei Same Remainder of hypothalamus
Amygdala Amygdalopiriform transition area Same Central and medial nuclei
Cortical amygdaloid nuclei
Lateral n. basolateral nuclei
Basomedial nuclei
Basal ganglia None None Caudate, putamen, globus pallidus
Cranial nerve related Supraocular nuclei Same Trigeminal
Cochlear nuclei
Prepositus hypoglossal
Vestibular nuclei
Spinal trigeminal nuclei
Colliculus Subset of neurons Same
Superficial gray
Cerebellum Granule cells Granule cells
Molecular layer neurons Molecular layer neurons
Deep cerebellar nuclei NOT deep cerebellar nuclei
Brainstem Ext. cuneate nucleus Ext. cuneate nucleus Raphe nucleus
Central gray NOT central gray
Pontine nuclei
Pyramidal nuclei
Miscellaneous Nucleus of Darkschewitsch Same Mammillary bodies
Periaqueductal gray
Geniculate nuclei
Supramammillary nuclei
Superficial gray
Olfactory bulb
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promoter activity
We developed transgenic mice that utilized either a 10- or
1-kb fragment of the neuroD2 promoter to drive the h-
galactosidase gene (10 kb:lacZ and 1 kb:lacZ mice, respec-
tively, Fig. 4). The 10 kb:lacZ mice express h-galactosidase
in the same neuronal populations as the endogenous neu-
roD2 promoter indicating that all of the promoter elements
that are necessary for neuroD2 expression are contained
within this region (Fig. 4 and Table 1). In contrast, 1 kb:lacZ
mice failed to express h-galactosidase in several layers of
the cerebral cortex (Figs. 4C and L), in CA3 of the
hippocampus (Figs. 4C and F, arrow), deep cerebellar
nuclei, and brainstem central gray matter (not shown). The
staining pattern in 1 kb:lacZ mice otherwise recapitulated
neuroD2+/ and 10 kb:lacZ mice (Fig. 4 and Table 1). Note
that the 10 kb:lacZ and 1 kb:lacZ mice have a nuclear
localization signal (NLS) on the h-galactosidase gene,
accounting for the difference in gross appearance between
neuroD2+/ mice which do not have an NLS.
Like the endogenous promoter, the 1- and 10-kb-driven
reporters were active by embryonic day E13.5. At thisearly stage, the differences between the two promoters
were more pronounced than in adult mice. h-galactosidase
staining was present in the olfactory lobe, neopallial
cortex, the ventral region of the midbrain, the cerebellar
primordium, and dorsal and ventral medulla oblongata of
E13 10 kb:lacZ embryos, but was restricted to the ventral
part of the midbrain, cerebellar primordium, and dorsal
and ventral medulla oblongata in 1 kb:lacZ embryos
(Figs. 4M–O).
To establish the importance of E4 and E5 in the context
of mammalian brain neurons, we developed additional
transgenic mice that utilized the 1 kb:lacZ construct with
mutations of E4 and E5 (mutE4E5:lacZ). The brains of
these mice were completely devoid of h-galactosidase
activity at all ages (Figs. 5C, F, and G). To ensure that this
was not due to an unexpected sequence error in the
transgenic mice, we performed transgene sequencing and
genomic southern analyses on four distinct mouse lines and
found no sequence errors and expected transgene compo-
nents, respectively (data not shown and Fig. 5H). Therefore,
the absence of h-galactosidase activity in these mice clearly
demonstrates that E4 and E5 are critical components of the
proximal neuroD2 promoter.
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To determine the influence of neurogenin1 and neuroge-
nin2 on neuroD2 expression, we obtained neurogenin1+/
and neurogenin2+/ mice and bred them with neuroD2+/
mice. Through multiple rounds of breeding, we generated
embryos that contained the h-galactosidase gene in place of
the neuroD2 coding sequence and were null for neurogenin1
(ngn1/:nd2+/) or neurogenin2 (ngn2/:nd2+/).
Because neurogenin1/ and neurogenin2/ mice die
shortly after birth, lacZ staining was done only at E13 and
P0.5. For E13.5 embryos in the absence of neurogenin1, the
endogenous neuroD2 promoter was less active in the neo-
pallial cortex compared to controls (Figs. 6A–D). By P0.5,
in the absence of neurogenin1, neuroD2 promoter activity
was restricted to the intermediate zone of the cerebral
cortex, and was missing from the cortical plate, including
the superficial layers where it is normally expressed in the
vast majority of neurons. The number and density of
neurons in these structures were unchanged in neuroge-
nin1-null mice compared to controls, suggesting that the cell
types that normally express neuroD2 are not specifically
missing. NeuroD2-lacZ expression was also missing from
the mitral cell layer in the neurogenin1 mutant olfactory
bulb, where it is normally present at high level (Figs. 6C–
D). We have not observed a consistent difference in neu-
roD2 expression between wild type and neurogenin2 mutant
brain (Fig. 6).
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In the developing mammalian brain, a small number of
bHLH and other neurogenic transcription factors act in a
combinatorial fashion to influence the fate of neuronal cells.
The spatial and temporal expression patterns of each tran-
scription factor serve as templates for the rich diversity of
neuronal subtypes.
In this study, we evaluated neuroD2 gene regulation in
mouse brain. We presented an analysis of neuronal popula-
tions in which the endogenous neuroD2 promoter is active
and demonstrated by generating transgenic mice that all of
the necessary regulatory elements appear to be present in a
10-kb fragment of DNA immediately upstream of the
transcriptional start site. A 1-kb fragment was sufficient to
recapitulate endogenous neuroD2 expression patterns in
most neuronal populations, but apparently lacked critical
response elements that are necessary for expression in
subsets of cortical neurons. Although we have not identified
these regulatory elements, comparison of human and mouse
sequences shows two regions of significant homology.
These regions correspond with the murine promoter region
(base pairs 1 to 2583 relative to the translation start
codon) and a region about 5-kb upstream of the promoter
(4454 to 6635). The latter may be a suitable startingpoint for future studies that map the distal regulatory
elements.
In the proximal regulatory region, E4 is recognized by
neurogenin and neuroD family members and is particularly
responsive to neurogenin1. The importance of this E-box in
mammalian brain is demonstrated by the absence of neuroD2
1-kb promoter activity following mutation of E4 and E5.
Mutation of E5 reduced the response of a 0.5-kb reporter
construct to neurogenin1 in NSH cells. Since neurogenin and
neuroD family members failed to bind E5 in electrophoretic
mobility shift assays, we conclude that neurogenin does not
directly regulate neuroD2 via E5. This notion is supported by
the fact that E4 but not E5 is conserved between mice and
humans. Deletion of the promoter region that contains E6
and E7 caused approximately 30% decline in neurogenin1-
induced reporter activity. This region does not contain
elements that are sufficient to promote gene expression in
vivo, however, since transgene expression was eliminated by
mutation of E4 and E5 in mice. An alternative explanation is
that promoter elements other than E-boxes play a modulatory
role in neuroD2 expression only after the promoter is
activated by transcription factors that utilize E4.
Complete absence of neuroD2 promoter activity in super-
ficial layers of the neocortex of P0.5 mice that lack neuro-
genin1 underscore the importance of neurogenin1 in the
regulation of neuroD2 in mammalian brain. NeuroD2 pro-
moter activity was similar in the presence and absence of
neurogenin2 at both ages. Coupled with consistently weak
binding of neurogenin2 to E4 in gel shift assays, these data
suggest that neurogenin2 may have little influence on neu-
roD2 expression. It is possible that neurogenin family mem-
bers differentially regulate neuroD family members based on
affinity for particular response elements in the neuroD family
promoters. Additionally, the extent of neurogenin1 or neuro-
genin2 regulation of neuroD2may be underestimated in these
studies due to functional redundancy between neurogenin
family members that share homology and overlapping ex-
pression patterns (Fode et al., 1998; Ma et al., 1996, 1998).
Because neurogenin family members are only transiently
expressed during development, neurogenin1 cannot account
for long-term expression of neuroD2 postnatally. Further-
more, while neuroD2 expression, like several other bHLH
proteins, has been shown to be autoregulatory and the
neuroD2 promoter is transactivated by neuroD2, autoregu-
lation cannot account for the majority of neuroD2 promoter
activity in adulthood as evidenced by persistent expression
of the lacZ gene (driven by the endogenous neuroD2
promoter) in neuroD2-null mice. The most likely alternative
is that neuroD2 expression is largely regulated by neuroD1.
In developing mouse brain and differentiating P19 cells,
neuroD1 expression precedes neuroD2 expression and neu-
roD1 transactivated the neuroD2 promoter reporter con-
structs in both P19 and NSH cells. Comparison of
neuroD1 and neuroD2 expression reveals broadly overlap-
ping patterns in cerebral cortex, hippocampus, cerebellum,
and cranial nerve ganglia.
C.-H. Lin et al. / Developmental Biology 265 (2004) 234–245 245In addition to providing insight into regulation of neu-
roD2 in neurons that are critical for memory, learning,
balance, and cranial nerve function, this study provided
information about neuroD2 promoter fragments that might
be useful for generation of future transgenic mice. For
example, the 1-kb promoter fragment is particularly useful
for driving gene expression in cerebellar granule cells,
granule cell precursors, and hippocampal dentate gyrus
without expression in most cerebral cortex, thalamic or
basal ganglia neurons. Crossing the neuroD2+/ or 1
kb:lacZ mice with mice that lack other neurodevelopmental
factors offers a tool for understanding which transcription
factors are necessary for production and migration of
neuroD2-expressing neurons.Acknowledgments
NIH/NINDS-NS36086 to SJT and Burroughs Wellcome
Fund Career Award in Biomedical Science to JMO.References
Blader, P., Fischer, N., Gradwohl, G., Guillemont, F., Strahle, U., 1997. The
activity of neurogenin1 is controlled by local cues in the zebrafish
embryo. Development 124, 4557–4569.
Farah, M.H., Olson, J.M., Sucic, H.B., Hume, R.I., Tapscott, S.J., Turner,
D.L., 2000. Generation of neurons by transient expression of neural
bHLH proteins in mammalian cells. Development 127, 693–702.Fode, C., Gradwohl, G., Morin, X., Dierich, A., LeMeur, M., Goridis, C.,
Guillemot, F., 1998. The bHLH protein NEUROGENIN 2 is a deter-
mination factor for epibranchial placode-derived sensory neurons. Neu-
ron 20, 483–494.
Huang, H.P., Liu, M., El-Hodiri, H.M., Chu, K., Jamrich, M., Tsai, M.J.,
2000. Regulation of the pancreatic islet-specific gene BETA2 (neuroD)
by neurogenin 3. Mol. Cell. Biol. 20, 3292–3307.
Koyano-Nakagawa, N., Wettstein, D., Kintner, C., 1999. Activation of
Xenopus genes required for lateral inhibition and neuronal differentia-
tion during primary neurogenesis. Mol. Cell. Neurosci. 14, 327–339.
Ma, Q., Kintner, C., Anderson, D.J., 1996. Identification of neurogenin, a
vertebrate neuronal determination gene. Cell 87, 43–52.
Ma, Q., Chen, Z., del Barco Barrantes, I., de la Pompa, J.L., Anderson,
D.J., 1998. Neurogenin1 is essential for the determination of neuronal
precursors for proximal cranial sensory ganglia. Neuron 20, 469–482.
McCormick, M.B., Tamimi, R.M., Snider, L., Asakura, A., Bergstrom, D.,
Tapscott, S.J., 1996. NeuroD2 and neuroD3: distinct expression patterns
and transcriptional activation potentials within the neuroD gene family.
Mol. Cell. Biol. 16, 5792–5800.
Nieto, M., Schuurmans, C., Britz, O., Guillemot, F., 2001. Neural bHLH
genes control the neuronal versus glial fate decision in cortical progen-
itors. Neuron 29, 401–413.
Oda, H., Iwata, I., Yasunami, M., Ohkubo, H., 2000. Structure of the mouse
NDRF gene and its regulation during neuronal differentiation of P19
cells. Brain Res. Mol. Brain Res. 77, 37–46.
Olson, J.M., Asakura, A., Snider, L., Hawkes, R., Strand, A., Stoeck, J.,
Hallahan, A., Pritchard, J., Tapscott, S.J., 2001. NeuroD2 is necessary
for development and survival of central nervous system neurons. Dev.
Biol. 234, 174–187.
Perez, S.E., Rebelo, S., Anderson, D.J., 1999. Early specification of sen-
sory neuron fate revealed by expression and function of neurogenins in
the chick embryo. Development 126, 1715–1728.
Sun, Y., Nadal-Vicens, M., Misono, S., Lin, M.Z., Zubiaga, A., Hua, X.,
Fan, G., Greenberg, M.E., 2001. Neurogenin promotes neurogenesis
and inhibits glial differentiation by independent mechanisms. Cell
104, 365–376.
